In this study we demonstrated that only two obesity-related biomarkers, namely adiponectin and TNF-α R2, were required to achieve an effect comparable to 2-hour glucose, when added to a predictive model consisting of non-invasively assessable clinical parameters together with fasting glucose and lipid levels. The gene discussed is TNF; the disease is Obesity.